Managing randomization and trial supply comes with challenges - complex study builds, design changes, system integration issues, and visibility gaps can all impact trial efficiency.

This webinar explores key trial hurdles and how clever solutions make life easier for study, supply, data, and vendor managers.

We'll cover:

• Study build efficiency - getting trials ready faster
• Flexible design - adapting without disruptions
• Real-time reporting - improving visibility and compliance
• Reliable support - expert guidance when you need it

Speaker:

Ashish Patel,
Associate Director, Project & Program Management
Perceptive eClinical

 Digital endpoints have finally come of age. No longer a technical risk, they are now supported by final guidance documents, regulatory qualifications, and real-world case studies. Even more compelling, new data and publications show measurable ROI—giving us the tools to make a clear business case. In this session, we’ll explore how digital endpoints are helping sponsors streamline trials, gain competitive advantage, and position for broad enterprise adoption.

Learning Objectives:

• Examine case studies from leading pharmaceutical companies and biotech innovators demonstrating ROI from digital endpoints
• Analyze how digital endpoints are reshaping competitive dynamics through decentralization and enterprise-level data strategies
• Identify key business language and tactics used to accelerate digital endpoint adoption across clinical development portfolios 

Speaker:

Jennifer Goldsack, MChem, MA, MBA, OLY
CEO
Digital Medicine Society (DiMe)

What if the most critical technology in your clinical trial is also the least understood?

In today’s evolving research landscape, Interactive Response Technology (IRT) has outgrown its legacy role as a randomization and supply tool. It now sits at the core of operational success—enabling mid-study agility, streamlining site workflows, supporting decentralisation, and shaping the participant experience.

In this expert-led fireside chat, senior leaders from Almac Clinical Technologies—Abi Pesun and Mike Hutton—discuss how sponsors are leveraging IRT to orchestrate the entire clinical trial value chain, from protocol design to participant dosing.

The conversation offers practical insights and field-tested strategies grounded in 25+ years of IRT deployment across global, complex trials.

Attendees will learn:

• How modern IRT supports agility, compliance, and integration across CTMS, EDC, and eCOA
• Where IRT adds value for sponsors, CROs, sites, and participants alike
• How to reduce risk and burden at sites through automation and configurability
• What to consider when designing IRT for adaptive, global, and decentralised studies
• Lessons from real-world oncology trials, including mid-study changes and supply efficiency

Whether you're overseeing global operations or driving digital transformation, this session will help you unlock the strategic potential of IRT as a unifying force in trial execution.

Speaker:

Abi Pesun
VP UK Operations, Clinical Project Services
Almac Clinical Technologies

Brian Mullin
Associate Director – Strategic Solutions
Almac Clinical Technologies